Hertraz 440 Mg Trastuzumab Injection

Hertraz 440 Mg Trastuzumab Injection Specification

Dosage Form
Injection

Life Span
24 months

Packaging Type
Box

Pacakaging (Quantity Per Box)
1 vial + solvent

Brand Name
Hertraz 440mg Injection

Indication
HER2+ metastatic or early breast cancer, HER2+ gastric cancer

Salt Composition
Trastuzumab

Origin of Medicine
India

Drug Type
Biological

Ingredients
Trastuzumab

Physical Form
Lyophilized Powder

Function
Anticancer, HER2 receptor blockade

Recommended For
HER2-positive breast cancer & gastric cancer

Dosage
As directed by physician

Dosage Guidelines
Intravenous use only

Suitable For
Adults

Quantity
50 ml

Storage Instructions
Store at 2C-8C, Do not freeze

Solvent Included
Yes

Usage
Hospital only

Appearance
Sterile white powder

Route of Administration
IV infusion

Strength
440 mg/vial

Reconstitution Required
Yes

Hertraz 440 Mg Trastuzumab Injection Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About Hertraz 440 Mg Trastuzumab Injection

Hertraz 440 mg Trastuzumab Injection is a trending and illustrious treatment option for patients diagnosed with HER2-positive breast or gastric cancers. Capitalise on the monumental advancements in oncology by buying this kingly solution, offering a robust HER2 receptor blockade via IV infusion. Each vial contains 440 mg of sterile lyophilized powder, reconstituted just before use. Packaged with a solvent and manufactured in India, this product is recommended for hospital settings. Trust in Hertraz 440mg to deliver sophisticated, evidence-based cancer care, exported and supplied through reputable traders and wholesalers.

Essential Clinical Use and Noteworthy Features

Hertraz 440 Mg Trastuzumab Injection is primarily used for HER2-positive metastatic or early breast cancer, as well as HER2-positive gastric cancer. Specifically intended for adult hospital patients, this sterile white lyophilized powder must be reconstituted before intravenous administration. An extra feature is that the solvent is included, simplifying preparation. Hertraz delivers kingly effectiveness by precisely targeting the HER2 receptor, reflecting a monumental leap in targeted cancer therapy.

Domestic Availability, Sampling, and Delivery Protocol

Hertraz 440 Mg Trastuzumab Injection has a strong presence in the esteemed domestic market of India. Sample policies are thoughtfully structured to allow for streamlined exchanges to support evaluation. Goods are generally shipped within an estimated delivery timeframe, as agreed with the supplier. Rigorously packed in a box containing a single vial plus solvent, the process ensures the quality and safety of the shipped goods reach the client in optimal condition.

FAQ's of Hertraz 440 Mg Trastuzumab Injection:

Q: How should Hertraz 440 Mg Trastuzumab Injection be administered?

A: Hertraz 440 Mg Trastuzumab Injection is administered as an intravenous infusion in hospital settings. The lyophilized powder must be reconstituted with the included solvent before use and given strictly under medical supervision.

Q: What is the recommended storage condition for Hertraz 440 Mg Trastuzumab Injection?

A: It should be stored between 2C and 8C. Do not freeze. Always keep the vial and solvent in their original packaging until use to maintain sterility and stability.

Q: When is Hertraz 440 Mg Trastuzumab Injection prescribed?

A: Hertraz is prescribed for adults diagnosed with HER2-positive metastatic or early breast cancer, and HER2-positive gastric cancer, following the dosage guidelines provided by the physician.

Q: Where is Hertraz 440 Mg Trastuzumab Injection available for purchase?

A: The injection is available through registered exporters, wholesalers, suppliers, and traders across India's pharmaceutical market, predominantly for hospital use.

Q: What are the main benefits of using Hertraz 440 Mg Trastuzumab Injection?

A: The main benefit is its effectiveness in targeting and blocking the HER2 receptor, resulting in improved treatment outcomes for HER2-positive breast and gastric cancers, with a well-controlled safety profile under professional supervision.

Tell us about your requirement